|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(State of incorporation)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
(title of security)
|
(ticker symbol)
|
(Name of exchange on which registered)
|
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer (do not check if smaller reporting company)
|
☐
|
Smaller reporting company
|
|
Emerging growth company
|
|
Item 1.
|
Financial Statements.
|
3/31/2020
|
12/31/2019
|
|||||||
ASSETS
|
||||||||
Cash and cash equivalents
|
$
|
|
|
$
|
|
|
||
Accounts receivable and accrued revenue
|
|
|
|
|
||||
Investments
|
|
|
|
|
||||
Assets of consolidated T. Rowe Price investment products ($1,795.8 million at March 31, 2020 and $1,975.3 million at December 31, 2019, related to variable interest entities)
|
|
|
|
|
||||
Operating lease assets
|
|
|
|
|
||||
Property and equipment, net
|
|
|
|
|
||||
Goodwill
|
|
|
|
|
||||
Other assets
|
|
|
|
|
||||
Total assets
|
$
|
|
|
$
|
|
|
||
LIABILITIES
|
||||||||
Accounts payable and accrued expenses
|
$
|
|
|
$
|
|
|
||
Liabilities of consolidated T. Rowe Price investment products ($72.0 million at March 31, 2020 and $27.0 million at December 31, 2019, related to variable interest entities)
|
|
|
|
|
||||
Operating lease liabilities
|
|
|
|
|
||||
Accrued compensation and related costs
|
|
|
|
|
||||
Supplemental savings plan liability
|
|
|
|
|
||||
Income taxes payable
|
|
|
|
|
||||
Total liabilities
|
|
|
|
|
||||
Commitments and contingent liabilities
|
|
|
|
|
||||
Redeemable non-controlling interests
|
|
|
|
|
||||
STOCKHOLDERS’ EQUITY
|
||||||||
Preferred stock, undesignated, $.20 par value – authorized and unissued 20,000,000 shares
|
|
|
|
|
||||
Common stock, $.20 par value—authorized 750,000,000; issued 227,985,000 shares at March 31, 2020 and 235,214,000 at December 31, 2019
|
|
|
|
|
||||
Additional capital in excess of par value
|
|
|
|
|
||||
Retained earnings
|
|
|
|
|
||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Total permanent stockholders’ equity
|
|
|
|
|
||||
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity
|
$
|
|
|
$
|
|
|
|
Three months ended
|
||||||
|
3/31/2020
|
3/31/2019
|
|||||
Revenues
|
|||||||
Investment advisory fees
|
$
|
|
|
$
|
|
|
|
Administrative, distribution, and servicing fees
|
|
|
|
|
|||
Net revenues
|
|
|
|
|
|||
Operating expenses
|
|||||||
Compensation and related costs
|
|
|
|
|
|||
Distribution and servicing
|
|
|
|
|
|||
Advertising and promotion
|
|
|
|
|
|||
Product-related costs
|
|
|
|
|
|||
Technology, occupancy, and facility costs
|
|
|
|
|
|||
General, administrative, and other
|
|
|
|
|
|||
Total operating expenses
|
|
|
|
|
|||
Net operating income
|
|
|
|
|
|||
Non-operating income (loss)
|
|||||||
Net gains (losses) on investments
|
(
|
)
|
|
|
|||
Net gains (losses) on consolidated investment products
|
(
|
)
|
|
|
|||
Other income (loss)
|
(
|
)
|
|
|
|||
Total non-operating income (loss)
|
(
|
)
|
|
|
|||
Income before income taxes
|
|
|
|
|
|||
Provision for income taxes
|
|
|
|
|
|||
Net income
|
|
|
|
|
|||
Less: net income (loss) attributable to redeemable non-controlling interests
|
(
|
)
|
|
|
|||
Net income attributable to T. Rowe Price Group
|
$
|
|
|
$
|
|
|
|
Earnings per share on common stock of T. Rowe Price Group
|
|||||||
Basic
|
$
|
|
|
$
|
|
|
|
Diluted
|
$
|
|
|
$
|
|
|
|
Three months ended
|
||||||
|
3/31/2020
|
3/31/2019
|
|||||
Net income
|
$
|
|
|
$
|
|
|
|
Other comprehensive income (loss)
|
|||||||
Currency translation adjustments
|
|||||||
Consolidated T. Rowe Price investment products - variable interest entities
|
(
|
)
|
(
|
)
|
|||
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products
|
(
|
)
|
(
|
)
|
|||
Total currency translation adjustments of consolidated T. Rowe Price investment products - variable interest entities
|
(
|
)
|
(
|
)
|
|||
Equity method investments
|
(
|
)
|
|
|
|||
Other comprehensive loss before income taxes
|
(
|
)
|
(
|
)
|
|||
Net deferred tax benefits
|
|
|
|
|
|||
Total other comprehensive loss
|
(
|
)
|
(
|
)
|
|||
Total comprehensive income
|
|
|
|
|
|||
Less: comprehensive income (loss) attributable to redeemable non-controlling interests
|
(
|
)
|
|
|
|||
Total comprehensive income attributable to T. Rowe Price Group
|
$
|
|
|
$
|
|
|
|
Three months ended
|
||||||
|
3/31/2020
|
3/31/2019
|
|||||
Cash flows from operating activities
|
|||||||
Net income
|
$
|
|
|
$
|
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|||||||
Depreciation and amortization of property and equipment
|
|
|
|
|
|||
Stock-based compensation expense
|
|
|
|
|
|||
Net (gains) losses recognized on investments
|
|
|
(
|
)
|
|||
Net investments in T. Rowe Price investment products used to economically hedge supplemental savings plan liability
|
(
|
)
|
(
|
)
|
|||
Net change in securities held by consolidated T. Rowe Price investment products
|
|
|
(
|
)
|
|||
Other changes in assets and liabilities
|
|
|
|
|
|||
Net cash provided by operating activities
|
|
|
|
|
|||
Cash flows from investing activities
|
|||||||
Purchases of T. Rowe Price investment products
|
(
|
)
|
(
|
)
|
|||
Dispositions of T. Rowe Price investment products
|
|
|
|
|
|||
Net cash of T. Rowe Price investment products on deconsolidation
|
(
|
)
|
(
|
)
|
|||
Additions to property and equipment
|
(
|
)
|
(
|
)
|
|||
Other investing activity
|
|
|
(
|
)
|
|||
Net cash provided by (used in) investing activities
|
|
|
(
|
)
|
|||
Cash flows from financing activities
|
|||||||
Repurchases of common stock
|
(
|
)
|
(
|
)
|
|||
Common share issuances under stock-based compensation plans
|
|
|
|
|
|||
Dividends paid to common stockholders of T. Rowe Price Group
|
(
|
)
|
(
|
)
|
|||
Net subscriptions received from redeemable non-controlling interest holders
|
|
|
|
|
|||
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
|||
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
|
(
|
)
|
(
|
)
|
|||
Net change in cash and cash equivalents during period
|
(
|
)
|
|
|
|||
Cash and cash equivalents at beginning of period, including $76.5 million at December 31, 2019, and $70.1 million at December 31, 2018, held by consolidated T. Rowe Price investment products
|
|
|
|
|
|||
Cash and cash equivalents at end of period, including $117.7 million at March 31, 2020, and $76.1 million at March 31, 2019, held by consolidated T. Rowe Price investment products
|
$
|
|
|
$
|
|
|
Three months ended 3/31/2020
|
||||||||||||||||||||||||||
Common
shares outstanding |
Common
stock |
Additional
capital in excess of par value |
Retained
earnings |
AOCI
(1)
|
Total
stockholders’ equity |
Redeemable non-controlling interests
|
||||||||||||||||||||
Balances at December 31, 2019
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
||||||
Net income
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
|
|
(
|
)
|
||||||||||||
Other comprehensive loss, net of tax
|
—
|
|
—
|
|
—
|
|
—
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||
Dividends declared ($0.90 per share)
|
—
|
|
—
|
|
—
|
|
(
|
)
|
—
|
|
(
|
)
|
—
|
|
||||||||||||
Shares issued upon option exercises
|
|
|
|
|
|
|
—
|
|
—
|
|
|
|
—
|
|
||||||||||||
Net shares issued upon vesting of restricted stock units
|
|
|
—
|
|
(
|
)
|
—
|
|
—
|
|
(
|
)
|
—
|
|
||||||||||||
Stock-based compensation expense
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
|
|
—
|
|
||||||||||||
Restricted stock units issued as dividend equivalents
|
—
|
|
—
|
|
|
|
(
|
)
|
—
|
|
—
|
|
—
|
|
||||||||||||
Common shares repurchased
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
—
|
|
(
|
)
|
—
|
|
||||||||||||
Net subscriptions into T. Rowe Price investment products
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
||||||||||||
Net deconsolidations of T. Rowe Price investment products
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(
|
)
|
||||||||||||
Balances at March 31, 2020
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
||||||
Three months ended 3/31/2019
|
||||||||||||||||||||||||||
Common
shares outstanding |
Common
stock |
Additional
capital in excess of par value |
Retained
earnings |
AOCI
(1)
|
Total
stockholders’ equity |
Redeemable non-controlling interests
|
||||||||||||||||||||
Balances at December 31, 2018
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
||||||
Net income
|
—
|
|
—
|
|
—
|
|
|
|
—
|
|
|
|
|
|
||||||||||||
Other comprehensive income (loss), net of tax
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
|
|
(
|
)
|
||||||||||||
Dividends declared ($0.76 per share)
|
—
|
|
—
|
|
—
|
|
(
|
)
|
—
|
|
(
|
)
|
—
|
|
||||||||||||
Shares issued upon option exercises
|
|
|
|
|
|
|
—
|
|
—
|
|
|
|
—
|
|
||||||||||||
Net shares issued upon vesting of restricted stock units
|
|
|
—
|
|
(
|
)
|
—
|
|
—
|
|
(
|
)
|
—
|
|
||||||||||||
Forfeiture of restricted awards
|
(
|
)
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||||||
Stock-based compensation expense
|
—
|
|
—
|
|
|
|
—
|
|
—
|
|
|
|
—
|
|
||||||||||||
Common shares repurchased
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
—
|
|
(
|
)
|
—
|
|
||||||||||||
Net subscriptions into T. Rowe Price investment products
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
||||||||||||
Net reconsolidations of T. Rowe Price investment products
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
||||||||||||
Balances at March 31, 2019
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
Three months ended 3/31/2020
|
Three months ended 3/31/2019
|
||||||||||||||||||||||||||||||
Administrative, distribution, and servicing fees
|
Administrative, distribution, and servicing fees
|
||||||||||||||||||||||||||||||
(in millions)
|
Investment advisory fees
|
Administrative fees
|
Distribution and servicing fees
|
Net revenues
|
Investment advisory fees
|
Administrative fees
|
Distribution and servicing fees
|
Net revenues
|
|||||||||||||||||||||||
U.S. mutual funds
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||||||
Subadvised and separate accounts and other investment products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Other clients
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|
Three months ended
|
||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
|||||
U.S. mutual funds
|
|||||||
Equity and blended assets
|
$
|
|
|
$
|
|
|
|
Fixed income, including money market
|
|
|
|
|
|||
|
|
|
|
||||
Subadvised and separate accounts and other investment products
|
|||||||
Equity and blended assets
|
|
|
|
|
|||
Fixed income, including money market
|
|
|
|
|
|||
|
|
|
|
||||
Total
|
$
|
|
|
$
|
|
|
Average during
|
|||||||||||||||
three months ended
|
As of
|
||||||||||||||
(in billions)
|
3/31/2020
|
3/31/2019
|
3/31/2020
|
12/31/2019
|
|||||||||||
U.S. mutual funds
|
|||||||||||||||
Equity and blended assets
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||
Fixed income, including money market
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
||||||||
Subadvised and separate accounts and other investment products
|
|||||||||||||||
Equity and blended assets
|
|
|
|
|
|
|
|
|
|||||||
Fixed income, including money market
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
||||||||
Total
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(in millions)
|
3/31/2020
|
12/31/2019
|
|||||
Investments held at fair value
|
|||||||
T. Rowe Price investment products
|
$
|
|
|
$
|
|
|
|
T. Rowe Price investment products designated as an economic hedge of supplemental savings plan liability
|
|
|
|
|
|||
Investment partnerships and other investments
|
|
|
|
|
|||
Equity method investments
|
|||||||
T. Rowe Price investment products
|
|
|
|
|
|||
26% interest in UTI Asset Management Company Limited (India)
|
|
|
|
|
|||
Investment partnerships and other investments
|
|
|
|
|
|||
U.S. Treasury note
|
|
|
|
|
|||
Total
|
$
|
|
|
$
|
|
|
Three months ended
|
|||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
|||||
Net increase (decrease) in assets of consolidated T. Rowe Price investment products
|
$
|
(
|
)
|
$
|
|
|
|
Net decrease in liabilities of consolidated T. Rowe Price investment products
|
$
|
(
|
)
|
$
|
(
|
)
|
|
Net increase (decrease) in redeemable non-controlling interests
|
$
|
(
|
)
|
$
|
|
|
|
Gains recognized upon deconsolidation
|
$
|
|
|
$
|
|
|
(in millions)
|
3/31/2020
|
12/31/2019
|
|||||
Investment carrying values
|
$
|
|
|
$
|
|
|
|
Unfunded capital commitments
|
|
|
|
|
|||
Uncollected investment advisory and administrative fees
|
|
|
|
|
|||
$
|
|
|
$
|
|
|
|
securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data
|
3/31/2020
|
12/31/2019
|
||||||||||||||
(in millions)
|
Level 1
|
Level 2
|
Level 1
|
Level 2
|
|||||||||||
Cash equivalents held in T. Rowe Price money market funds
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||
T. Rowe Price investment products
|
|
|
|
|
|
|
|
|
|||||||
T. Rowe Price investment products designated as an economic hedge of supplemental savings plan liability
|
|
|
|
|
|
|
|
|
|||||||
Total
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
3/31/2020
|
12/31/2019
|
||||||||||||||||||||||
(in millions)
|
Voting
interest entities |
Variable interest entities
|
Total
|
Voting
interest entities |
Variable interest entities
|
Total
|
|||||||||||||||||
Cash and cash equivalents
(1)
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||||
Investments
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Other assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net assets
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||||
Attributable to T. Rowe Price Group
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||||
Attributable to redeemable non-controlling interests
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
Three months ended
|
|||||||||||||||||||||||
3/31/2020
|
3/31/2019
|
||||||||||||||||||||||
(in millions)
|
Voting interest entities
|
Variable interest entities
|
Total
|
Voting interest entities
|
Variable interest entities
|
Total
|
|||||||||||||||||
Operating expenses reflected in net operating income
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||
Net investment income (loss) reflected in non-operating income (loss)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
|
|
|
|
|||||||||||
Impact on income before taxes
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
$
|
|
|
|||||
Net income (loss) attributable to T. Rowe Price Group
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
$
|
|
|
|||||
Net income (loss) attributable to redeemable non-controlling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
|
|
|||||||||||
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
$
|
|
|
Three months ended
|
|||||||||||||||||||||||
3/31/2020
|
3/31/2019
|
||||||||||||||||||||||
(in millions)
|
Voting
interest entities |
Variable interest entities
|
Total
|
Voting
interest entities |
Variable interest entities
|
Total
|
|||||||||||||||||
Net cash provided by operating activities
|
$
|
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||
Net cash provided by (used in) investing activities
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
|||||||||||
Net cash used in financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products |
|
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
|||||||||||
Net change in cash and cash equivalents during period
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|||||||||||
Cash and cash equivalents at beginning of year
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Cash and cash equivalents at end of period
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
3/31/2020
|
12/31/2019
|
||||||||||||||
(in millions)
|
Level 1
|
Level 2
|
Level 1
|
Level 2
|
|||||||||||
Assets
|
|||||||||||||||
Cash equivalents
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
|||
Equity securities
|
|
|
|
|
|
|
|
|
|||||||
Fixed income securities
|
|
|
|
|
|
|
|
|
|||||||
Other investments
|
|
|
|
|
|
|
|
|
|||||||
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
||||
Liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Options
|
Weighted-
average
exercise
price
|
|||||
Outstanding at December 31, 2019
|
|
|
$
|
|
|
|
Exercised
|
(
|
)
|
$
|
|
|
|
Forfeited
|
(
|
)
|
$
|
|
|
|
Outstanding at March 31, 2020
|
|
|
$
|
|
|
|
Exercisable at March 31, 2020
|
|
|
$
|
|
|
Restricted
shares
|
Restricted
stock
units
|
Weighted-average
fair value
|
|||||||
Nonvested at December 31, 2019
|
|
|
|
|
$
|
|
|
||
Time-based grants
|
|
|
|
|
$
|
|
|
||
Dividend equivalents granted to non-employee directors
|
|
|
|
|
$
|
|
|
||
Vested
|
|
|
(
|
)
|
$
|
|
|
||
Forfeited
|
|
|
(
|
)
|
$
|
|
|
||
Nonvested at March 31, 2020
|
|
|
|
|
$
|
|
|
(in millions)
|
|||
Second quarter 2020
|
$
|
|
|
Third quarter 2020
|
|
|
|
Fourth quarter 2020
|
|
|
|
2021
|
|
|
|
2022 through 2026
|
|
|
|
Total
|
$
|
|
|
|
Three months ended
|
||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
|||||
Net income attributable to T. Rowe Price Group
|
$
|
|
|
$
|
|
|
|
Less: net income allocated to outstanding restricted stock and stock unit holders
|
|
|
|
|
|||
Net income allocated to common stockholders
|
$
|
|
|
$
|
|
|
|
Weighted-average common shares
|
|||||||
Outstanding
|
|
|
|
|
|||
Outstanding assuming dilution
|
|
|
|
|
Three months ended 3/31/2020
|
Three months ended 3/31/2019
|
|||||||||||||||||||||||
Currency translation adjustments
|
Currency translation adjustments
|
|||||||||||||||||||||||
(in millions)
|
Equity method investments
|
Consolidated T. Rowe Price investment products - variable interest entities
|
Total currency translation adjustments
|
Equity method investments
|
Consolidated T. Rowe Price investment products - variable interest entities
|
Total currency translation adjustments
|
||||||||||||||||||
Balances at beginning of period
|
$
|
(
|
)
|
$
|
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
$
|
(
|
)
|
||||||
Other comprehensive income (loss) before reclassifications and income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
|
|
||||||||||||
Reclassification adjustments recognized in non-operating income
|
|
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
||||||||||||
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
|
|
|||||||||||||
Net deferred tax benefits (income taxes)
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
||||||||||||
Other comprehensive income (loss)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
|
|
||||||||||||
Balances at end of period
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
$
|
(
|
)
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
Three months ended
|
||
Index
|
3/31/2020
|
|
S&P 500 Index
|
(19.6)%
|
|
NASDAQ Composite Index
(1)
|
(14.2)%
|
|
Russell 2000 Index
|
(30.6)%
|
|
MSCI EAFE (Europe, Australasia, and Far East) Index
|
(22.7)%
|
|
MSCI Emerging Markets Index
|
(23.6)%
|
Three months ended
|
||
Index
|
3/31/2020
|
|
Bloomberg Barclays U.S. Aggregate Bond Index
|
3.2%
|
|
JPMorgan Global High Yield Index
|
(14.9)%
|
|
Bloomberg Barclays Municipal Bond Index
|
(.6)%
|
|
Bloomberg Barclays Global Aggregate Ex-U.S. Dollar Bond Index
|
(2.7)%
|
|
JPMorgan Emerging Markets Bond Index Plus
|
(8.7)%
|
Three months ended 3/31/2020
|
|||||||||||||||
(in billions)
|
U.S. mutual funds
|
Subadvised and separate accounts
|
Other investment products
|
Total
|
|||||||||||
Assets under management at beginning of period
|
$
|
682.7
|
|
$
|
313.8
|
|
$
|
210.3
|
|
$
|
1,206.8
|
|
|||
Net cash flows before client transfers
|
(7.5
|
)
|
(3.5
|
)
|
5.0
|
|
(6.0
|
)
|
|||||||
Client transfers
|
(4.4
|
)
|
—
|
|
4.4
|
|
—
|
|
|||||||
Net cash flows after client transfers
|
(11.9
|
)
|
(3.5
|
)
|
9.4
|
|
(6.0
|
)
|
|||||||
Net market appreciation (depreciation) and income
|
(108.4
|
)
|
(49.2
|
)
|
(34.3
|
)
|
(191.9
|
)
|
|||||||
Net distributions reinvested (not reinvested)
|
(.1
|
)
|
—
|
|
—
|
|
(.1
|
)
|
|||||||
Change during the period
|
(120.4
|
)
|
(52.7
|
)
|
(24.9
|
)
|
(198.0
|
)
|
|||||||
Assets under management at March 31, 2020
|
$
|
562.3
|
|
$
|
261.1
|
|
$
|
185.4
|
|
$
|
1,008.8
|
|
Three months ended 3/31/2020
|
|||||||||||||||
(in billions)
|
Equity
|
Fixed income, including money market
|
Multi-asset
(1)
|
Total
|
|||||||||||
Assets under management at beginning of period
|
$
|
698.9
|
|
$
|
147.9
|
|
$
|
360.0
|
|
$
|
1,206.8
|
|
|||
Net cash flows
|
(5.7
|
)
|
3.0
|
|
(3.3
|
)
|
(6.0
|
)
|
|||||||
Net market appreciation (depreciation) and income
(2)
|
(123.9
|
)
|
(4.6
|
)
|
(63.5
|
)
|
(192.0
|
)
|
|||||||
Change during the period
|
(129.6
|
)
|
(1.6
|
)
|
(66.8
|
)
|
(198.0
|
)
|
|||||||
Assets under management at March 31, 2020
|
$
|
569.3
|
|
$
|
146.3
|
|
$
|
293.2
|
|
$
|
1,008.8
|
|
As of
|
|||||||
(in billions)
|
3/31/2020
|
12/31/2019
|
|||||
Target date retirement U.S. mutual funds
|
$
|
132.0
|
|
$
|
164.8
|
|
|
Target date separately managed retirement accounts
|
7.1
|
|
8.4
|
|
|||
Target date retirement trusts
|
103.1
|
|
119.2
|
|
|||
$
|
242.2
|
|
$
|
292.4
|
|
1 year
|
3 years
|
5 years
|
10 years
|
|||||
Outperformed Morningstar median
(2)
|
||||||||
All funds
|
50%
|
60%
|
72%
|
76%
|
||||
Multi-asset funds
|
44%
|
59%
|
76%
|
84%
|
||||
Top Morningstar quartile
(2)
|
||||||||
All funds
|
19%
|
28%
|
41%
|
50%
|
||||
Multi-asset funds
|
8%
|
24%
|
50%
|
68%
|
Three months ended
|
Q1 2020 vs. Q1 2019
|
|||||||||||||
(in millions, except per-share data)
|
3/31/2020
|
3/31/2019
|
$ change
|
% change
|
||||||||||
U.S. GAAP basis
|
||||||||||||||
Investment advisory fees
|
$
|
1,327.8
|
|
$
|
1,194.2
|
|
$
|
133.6
|
|
11.2
|
%
|
|||
Net revenues
|
$
|
1,462.6
|
|
$
|
1,327.3
|
|
$
|
135.3
|
|
10.2
|
%
|
|||
Operating expenses
|
$
|
755.4
|
|
$
|
794.8
|
|
$
|
(39.4
|
)
|
(5.0
|
)%
|
|||
Net operating income
|
$
|
707.2
|
|
$
|
532.5
|
|
$
|
174.7
|
|
32.8
|
%
|
|||
Non-operating income (loss)
(1)
|
$
|
(500.3
|
)
|
$
|
202.8
|
|
$
|
(703.1
|
)
|
n/m
|
|
|||
Net income attributable to T. Rowe Price Group
|
$
|
343.1
|
|
$
|
512.6
|
|
$
|
(169.5
|
)
|
(33.1
|
)%
|
|||
Diluted earnings per common share
|
$
|
1.41
|
|
$
|
2.09
|
|
$
|
(.68
|
)
|
(32.5
|
)%
|
|||
Weighted average common shares outstanding assuming dilution
|
236.8
|
|
239.6
|
|
(2.8
|
)
|
(1.2
|
)%
|
||||||
Adjusted non-GAAP basis
(2)
|
||||||||||||||
Operating expenses
|
$
|
817.9
|
|
$
|
756.6
|
|
$
|
61.3
|
|
8.1
|
%
|
|||
Net operating income
|
$
|
647.2
|
|
$
|
572.2
|
|
$
|
75.0
|
|
13.1
|
%
|
|||
Non-operating income (loss)
(1)
|
$
|
(61.2
|
)
|
$
|
44.2
|
|
$
|
(105.4
|
)
|
n/m
|
|
|||
Net income attributable to T. Rowe Price Group
|
$
|
454.3
|
|
$
|
460.6
|
|
$
|
(6.3
|
)
|
(1.4
|
)%
|
|||
Diluted earnings per common share
|
$
|
1.87
|
|
$
|
1.87
|
|
$
|
—
|
|
—
|
%
|
|||
Assets under management (in billions)
|
||||||||||||||
Average assets under management
|
$
|
1,162.7
|
|
$
|
1,043.5
|
|
$
|
119.2
|
|
11.4
|
%
|
|||
Ending assets under management
|
$
|
1,008.8
|
|
$
|
1,081.7
|
|
$
|
(72.9
|
)
|
(6.7
|
)%
|
Three months ended
|
Q1 2020 vs. Q1 2019
|
|||||||||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
$ change
|
% change
|
||||||||||
Investment advisory fees
|
||||||||||||||
U.S. mutual funds
|
$
|
876.2
|
|
$
|
815.9
|
|
$
|
60.3
|
|
7.4
|
%
|
|||
Subadvised and separate accounts and other investment products
|
451.6
|
|
378.3
|
|
73.3
|
|
19.4
|
%
|
||||||
1,327.8
|
|
1,194.2
|
|
133.6
|
|
11.2
|
%
|
|||||||
Administrative, distribution, and servicing fees
|
||||||||||||||
Administrative fees
|
106.9
|
|
102.9
|
|
4.0
|
|
3.9
|
%
|
||||||
Distribution and servicing fees
|
27.9
|
|
30.2
|
|
(2.3
|
)
|
(7.6
|
)%
|
||||||
134.8
|
|
133.1
|
|
1.7
|
|
1.3
|
%
|
|||||||
Net revenues
|
$
|
1,462.6
|
|
$
|
1,327.3
|
|
$
|
135.3
|
|
10.2
|
%
|
Three months ended
|
Q1 2020 vs. Q1 2019
|
|||||||||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
$ change
|
% change
|
||||||||||
Compensation and related costs
|
$
|
440.7
|
|
$
|
491.5
|
|
$
|
(50.8
|
)
|
(10.3
|
)%
|
|||
Distribution and servicing
|
65.7
|
|
66.4
|
|
(.7
|
)
|
(1.1
|
)%
|
||||||
Advertising and promotion
|
24.9
|
|
21.6
|
|
3.3
|
|
15.3
|
%
|
||||||
Product-related costs
|
41.6
|
|
44.2
|
|
(2.6
|
)
|
(5.9
|
)%
|
||||||
Technology, occupancy, and facility costs
|
105.4
|
|
98.1
|
|
7.3
|
|
7.4
|
%
|
||||||
General, administrative, and other
|
77.1
|
|
73.0
|
|
4.1
|
|
5.6
|
%
|
||||||
Total operating expenses
|
$
|
755.4
|
|
$
|
794.8
|
|
$
|
(39.4
|
)
|
(5.0
|
)%
|
Three months ended
|
|||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
|||||
Net gains (losses) from non-consolidated T. Rowe Price investment products
|
|||||||
Cash and discretionary investments
|
|||||||
Dividend income
|
$
|
10.4
|
|
$
|
16.2
|
|
|
Market related gains (losses) and equity in earnings
|
(71.6
|
)
|
28.0
|
|
|||
Seed capital investments
|
|||||||
Dividend income
|
.7
|
|
.5
|
|
|||
Market related gains (losses) and equity in earnings
|
(34.1
|
)
|
19.6
|
|
|||
Net gain recognized upon deconsolidation
|
.1
|
|
.1
|
|
|||
Investments used to hedge the supplemental savings plan liability
|
(68.5
|
)
|
31.0
|
|
|||
Total net gains (losses) from non-consolidated T. Rowe Price investment products
|
(163.0
|
)
|
95.4
|
|
|||
Other investment income
|
8.4
|
|
4.7
|
|
|||
Net gains (losses) on investments
|
(154.6
|
)
|
100.1
|
|
|||
Net gains (losses) on consolidated sponsored investment portfolios
|
(330.3
|
)
|
101.9
|
|
|||
Other income (loss), including foreign currency gains and losses
|
(15.4
|
)
|
.8
|
|
|||
Non-operating income (loss)
|
$
|
(500.3
|
)
|
$
|
202.8
|
|
Three months ended
|
|||||||
(in millions)
|
3/31/2020
|
3/31/2019
|
|||||
Operating expenses reflected in net operating income
|
$
|
(3.7
|
)
|
$
|
(3.1
|
)
|
|
Net investment income (loss) reflected in non-operating income (loss)
|
(330.3
|
)
|
101.9
|
|
|||
Impact on income before taxes
|
$
|
(334.0
|
)
|
$
|
98.8
|
|
|
Net income (loss) attributable to our interest in the consolidated T. Rowe Price investment products
|
$
|
(157.5
|
)
|
$
|
57.4
|
|
|
Net income (loss) attributable to redeemable non-controlling interests (unrelated third-party investors)
|
(176.5
|
)
|
41.4
|
|
|||
$
|
(334.0
|
)
|
$
|
98.8
|
|
Three months ended
|
|||||
3/31/2020
|
3/31/2019
|
||||
Statutory U.S. federal income tax rate
|
21.0
|
%
|
21.0
|
%
|
|
State income taxes for current year, net of federal income tax benefits
(1)
|
6.4
|
|
4.2
|
|
|
Net losses (income) attributable to redeemable non-controlling interests
|
3.1
|
|
(.6
|
)
|
|
Net excess tax benefits from stock-based compensation plans activity
|
(8.1
|
)
|
(.6
|
)
|
|
Other items
|
(2.9
|
)
|
.7
|
|
|
Effective income tax rate
|
19.5
|
%
|
24.7
|
%
|
Three months ended 3/31/2020
|
|||||||||||||||||||||||
Operating expenses
|
Net operating income
|
Non-operating income (loss)
|
Provision (benefit) for income taxes
(4)
|
Net income attributable to T. Rowe Price Group
|
Diluted earnings per share
(5)
|
||||||||||||||||||
U.S. GAAP Basis
|
$
|
755.4
|
|
$
|
707.2
|
|
$
|
(500.3
|
)
|
$
|
40.3
|
|
$
|
343.1
|
|
$
|
1.41
|
|
|||||
Non-GAAP adjustments:
|
|||||||||||||||||||||||
Consolidated T. Rowe Price
investment products (1) |
(1.2
|
)
|
3.7
|
|
330.3
|
|
71.1
|
|
86.4
|
|
.36
|
|
|||||||||||
Supplemental savings plan liability
(2)
|
63.7
|
|
(63.7
|
)
|
68.5
|
|
2.1
|
|
2.7
|
|
.01
|
|
|||||||||||
Other non-operating income
(3)
|
—
|
|
—
|
|
40.3
|
|
18.2
|
|
22.1
|
|
.09
|
|
|||||||||||
Adjusted Non-GAAP Basis
|
$
|
817.9
|
|
$
|
647.2
|
|
$
|
(61.2
|
)
|
$
|
131.7
|
|
$
|
454.3
|
|
$
|
1.87
|
|
Three months ended 3/31/2019
|
|||||||||||||||||||||||
Operating expenses
|
Net operating income
|
Non-operating income (loss)
|
Provision (benefit) for income taxes
(4)
|
Net income attributable to T. Rowe Price Group
|
Diluted earnings per share
(5)
|
||||||||||||||||||
U.S. GAAP Basis
|
$
|
794.8
|
|
$
|
532.5
|
|
$
|
202.8
|
|
$
|
181.3
|
|
$
|
512.6
|
|
$
|
2.09
|
|
|||||
Non-GAAP adjustments:
|
|||||||||||||||||||||||
Consolidated T. Rowe Price
investment products (1) |
(1.6
|
)
|
3.1
|
|
(101.9
|
)
|
(18.9
|
)
|
(38.5
|
)
|
(.16
|
)
|
|||||||||||
Supplemental savings plan liability
(2)
|
(36.6
|
)
|
36.6
|
|
(31.0
|
)
|
1.8
|
|
3.8
|
|
.01
|
|
|||||||||||
Other non-operating income
(3)
|
—
|
|
—
|
|
(25.7
|
)
|
(8.4
|
)
|
(17.3
|
)
|
(.07
|
)
|
|||||||||||
Adjusted Non-GAAP Basis
|
$
|
756.6
|
|
$
|
572.2
|
|
$
|
44.2
|
|
$
|
155.8
|
|
$
|
460.6
|
|
$
|
1.87
|
|
(1)
|
These non-GAAP adjustments remove the impact the consolidated T. Rowe Price investment products have on our U.S. GAAP consolidated statements of income. Specifically, we add back the operating expenses and subtract the investment income of the consolidated T. Rowe Price investment products. The adjustment to our operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interest. We remove the impact of the consolidated
|
(2)
|
These non-GAAP adjustments remove the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. We use T. Rowe Price investment products to economically hedge the exposure to these market movements. We believe it is useful to offset the non-operating investment income (loss) realized on the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand our core operating results and to increase comparability period to period.
|
(3)
|
This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on our non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and non-consolidated seed investments and other investments that are not part of the cash and discretionary investment portfolio.
We retain the investment gains recognized on our non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of our core operations. We believe adjusting for these non-operating income (loss) items helps the reader’s ability to understand our core operating results and increases comparability to prior years. Additionally, we do not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating our core performance.
|
(4)
|
The income tax impacts were calculated in order to achieve an overall non-GAAP effective tax rate of
22.5%
for
2020
and
25.3%
for
2019
. We estimate that our effective tax rate for the full-year
2020
on a non-GAAP basis will be in the range of
23.5%
to
25.5%
.
|
(5)
|
This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:
|
Three months ended
|
|||||||
3/31/2020
|
3/31/2019
|
||||||
Adjusted net income attributable to T. Rowe Price Group
|
$
|
454.3
|
|
$
|
460.6
|
|
|
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders
|
12.4
|
|
11.6
|
|
|||
Adjusted net income allocated to common stockholders
|
$
|
441.9
|
|
$
|
449.0
|
|
(in millions)
|
3/31/2020
|
12/31/2019
|
||||||
Cash and cash equivalents
|
$
|
1,562.4
|
|
$
|
1,781.8
|
|
||
Discretionary investments
|
1,841.4
|
|
1,899.6
|
|
||||
Total cash and discretionary investments
|
3,403.8
|
|
3,681.4
|
|
||||
Redeemable seed capital investments
|
1,081.6
|
|
1,325.6
|
|
||||
Investments used to hedge the supplemental savings plan liability
|
500.0
|
|
561.1
|
|
||||
Total cash and investments in T. Rowe Price products
|
$
|
4,985.4
|
|
$
|
5,568.1
|
|
(in millions)
|
Cash and cash equivalents
|
Investments
|
Net assets of consolidated T. Rowe Price investment products
(1)
|
3/31/2020
|
||||||||||||
Cash and discretionary investments
|
$
|
1,562.4
|
|
$
|
1,727.2
|
|
$
|
114.2
|
|
$
|
3,403.8
|
|
||||
Seed capital investments
|
—
|
|
225.4
|
|
856.2
|
|
1,081.6
|
|
||||||||
Investments used to hedge the supplemental savings plan liability
|
—
|
|
500.0
|
|
—
|
|
500.0
|
|
||||||||
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group
|
1,562.4
|
|
2,452.6
|
|
970.4
|
|
4,985.4
|
|
||||||||
Investment in UTI and other investments
|
—
|
|
278.7
|
|
—
|
|
278.7
|
|
||||||||
Total cash and investments attributable to T. Rowe Price Group
|
1,562.4
|
|
2,731.3
|
|
970.4
|
|
5,264.1
|
|
||||||||
Redeemable non-controlling interests
|
—
|
|
—
|
|
971.0
|
|
971.0
|
|
||||||||
As reported on unaudited condensed consolidated balance sheet at March 31, 2020
|
$
|
1,562.4
|
|
$
|
2,731.3
|
|
$
|
1,941.4
|
|
$
|
6,235.1
|
|
(1)
|
The T. Rowe Price investment products that we consolidate are generally those products we provided seed capital at the time of their formation and we have a controlling interest. These products generally represent U.S. mutual funds as well as those funds regulated outside the U.S. The net assets of the T. Rowe Price investment products at March 31, 2020 consist of the assets of these products that we consolidate on our unaudited condensed consolidated balance sheets of
$2,024.3 million
, less the liabilities of these products of
$82.9 million
.
|
(in millions)
|
Recurring dividend
|
Stock repurchases
|
Total cash returned to stockholders
|
||||||||
2018
|
$
|
694.7
|
|
$
|
1,099.6
|
|
$
|
1,794.3
|
|
||
2019
|
733.6
|
|
708.8
|
|
1,442.4
|
|
|||||
Three months ended 3/31/2020
|
214.7
|
|
887.0
|
|
1,101.7
|
|
|||||
Total
|
$
|
1,643.0
|
|
$
|
2,695.4
|
|
$
|
4,338.4
|
|
Three months ended
|
|||||||||||||||||||||||||||||||
3/31/2020
|
3/31/2019
|
||||||||||||||||||||||||||||||
(in millions)
|
Cash flow attributable to T. Rowe Price Group
|
Cash flow attributable to consolidated T. Rowe Price investment products
|
Elims
|
As reported
|
Cash flow attributable to T. Rowe Price Group
|
Cash flow attributable to consolidated T. Rowe Price investment products
|
Elims
|
As reported
|
|||||||||||||||||||||||
Cash flows from operating activities
|
|||||||||||||||||||||||||||||||
Net income
|
$
|
343.1
|
|
$
|
(334.0
|
)
|
$
|
157.5
|
|
$
|
166.6
|
|
$
|
512.6
|
|
$
|
98.8
|
|
$
|
(57.4
|
)
|
$
|
554.0
|
|
|||||||
Adjustments to reconcile net income to net cash provided by operating activities
|
|||||||||||||||||||||||||||||||
Depreciation and amortization of property and equipment
|
46.1
|
|
—
|
|
—
|
|
46.1
|
|
41.9
|
|
—
|
|
—
|
|
41.9
|
|
|||||||||||||||
Stock-based compensation expense
|
58.3
|
|
—
|
|
—
|
|
58.3
|
|
43.5
|
|
—
|
|
—
|
|
43.5
|
|
|||||||||||||||
Net (gains) losses recognized on investments
|
324.8
|
|
—
|
|
(157.5
|
)
|
167.3
|
|
(139.4
|
)
|
—
|
|
57.4
|
|
(82.0
|
)
|
|||||||||||||||
Net investments in T. Rowe Price investment products used to economically hedge supplemental savings plan liability
|
(8.9
|
)
|
—
|
|
—
|
|
(8.9
|
)
|
(18.2
|
)
|
—
|
|
—
|
|
(18.2
|
)
|
|||||||||||||||
Net change in trading securities held by consolidated T. Rowe Price investment products
|
—
|
|
234.6
|
|
—
|
|
234.6
|
|
—
|
|
(184.2
|
)
|
—
|
|
(184.2
|
)
|
|||||||||||||||
Other changes in assets and liabilities
|
100.6
|
|
23.7
|
|
(.6
|
)
|
123.7
|
|
233.0
|
|
(8.3
|
)
|
(1.0
|
)
|
223.7
|
|
|||||||||||||||
Net cash provided by (used in) operating activities
|
864.0
|
|
(75.7
|
)
|
(.6
|
)
|
787.7
|
|
673.4
|
|
(93.7
|
)
|
(1.0
|
)
|
578.7
|
|
|||||||||||||||
Net cash provided by (used in) investing activities
|
(15.0
|
)
|
(.8
|
)
|
43.4
|
|
27.6
|
|
(69.2
|
)
|
(3.4
|
)
|
38.8
|
|
(33.8
|
)
|
|||||||||||||||
Net cash provided by (used in) financing activities
|
(1,068.4
|
)
|
118.9
|
|
(42.8
|
)
|
(992.3
|
)
|
(372.0
|
)
|
103.8
|
|
(37.8
|
)
|
(306.0
|
)
|
|||||||||||||||
Effect of exchange rate changes on cash and cash equivalents of consolidated T. Rowe Price investment products
|
—
|
|
(1.2
|
)
|
—
|
|
(1.2
|
)
|
—
|
|
(.7
|
)
|
—
|
|
(.7
|
)
|
|||||||||||||||
Net change in cash and cash equivalents during period
|
(219.4
|
)
|
41.2
|
|
—
|
|
(178.2
|
)
|
232.2
|
|
6.0
|
|
—
|
|
238.2
|
|
|||||||||||||||
Cash and cash equivalents at beginning of year
|
1,781.8
|
|
76.5
|
|
—
|
|
1,858.3
|
|
1,425.2
|
|
70.1
|
|
—
|
|
1,495.3
|
|
|||||||||||||||
Cash and cash equivalents at end of period
|
$
|
1,562.4
|
|
$
|
117.7
|
|
$
|
—
|
|
$
|
1,680.1
|
|
$
|
1,657.4
|
|
$
|
76.1
|
|
$
|
—
|
|
$
|
1,733.5
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
(in millions)
|
Fair value 3/31/2020
|
Potential lower value
|
Potential
loss |
|||||||||||
Investments in T. Rowe Price products
|
||||||||||||||
Discretionary investments
|
$
|
961.9
|
|
$
|
865.6
|
|
$
|
96.3
|
|
10
|
%
|
|||
Seed capital not consolidated
|
126.2
|
|
112.8
|
|
13.4
|
|
11
|
%
|
||||||
Investments designated as an economic hedge of supplemental savings plan liability
|
500.0
|
|
441.6
|
|
58.4
|
|
12
|
%
|
||||||
Total
|
$
|
1,588.1
|
|
$
|
1,420.0
|
|
$
|
168.1
|
|
11
|
%
|
|||
Direct investment in consolidated T. Rowe Price investment products
|
||||||||||||||
Discretionary investments
|
$
|
114.2
|
|
$
|
100.5
|
|
$
|
13.7
|
|
12
|
%
|
|||
Seed capital
|
856.2
|
|
768.2
|
|
88.0
|
|
10
|
%
|
||||||
Total
|
$
|
970.4
|
|
$
|
868.7
|
|
$
|
101.7
|
|
10
|
%
|
|||
Investment partnerships and other investments held at fair value
|
$
|
105.5
|
|
$
|
91.7
|
|
$
|
13.8
|
|
13
|
%
|
Item 4.
|
Controls and Procedures.
|
Month
|
Total Number of
Shares Purchased
|
Average Price
Paid per Share
|
Total Number of
Shares Purchased as
Part of Publicly
Announced Program
|
Maximum Number of Shares that May Yet Be Purchased Under the Program
|
|||||||||
January
|
264,939
|
|
$
|
129.26
|
|
51,645
|
|
17,323,402
|
|
||||
February
|
1,325,194
|
|
$
|
125.41
|
|
1,190,000
|
|
16,133,402
|
|
||||
March
|
7,100,681
|
|
$
|
103.33
|
|
7,092,342
|
|
24,041,060
|
|
||||
Total
|
8,690,814
|
|
$
|
107.49
|
|
8,333,987
|
|
Authorization Dates
|
1/1/2020
|
Additional Shares Authorized
|
Total Number of
Shares Purchased |
Maximum Number of Shares that May Yet Be Purchased at 3/31/2020
|
||||||||
April 2018
|
7,375,047
|
|
—
|
|
(7,375,047
|
)
|
—
|
|
||||
February 2019
|
10,000,000
|
|
—
|
|
(958,940
|
)
|
9,041,060
|
|
||||
March 2020
|
—
|
|
15,000,000
|
|
—
|
|
15,000,000
|
|
||||
17,375,047
|
|
15,000,000
|
|
(8,333,987
|
)
|
24,041,060
|
|
Item 5.
|
Other Information.
|
3(i)
|
|
|
3(ii)
|
|
|
15
|
|
|
31(i).1
|
|
|
31(i).2
|
|
|
32
|
|
|
99.1
|
|
|
101
|
|
The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from T. Rowe Price Group’s unaudited condensed consolidated interim financial statements and notes that are included in this Form 10-Q Report.
|
101.INS
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL Taxonomy Calculation Linkbase Document
|
|
101.LAB
|
XBRL Taxonomy Label Linkbase Document
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase Document
|
|
101.DEF
|
XBRL Taxonomy Definition Linkbase Document
|
1.
|
I have reviewed this
Form 10-Q Quarterly Report
for the
quarterly period
ended
March 31, 2020
of T. Rowe Price Group, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
1.
|
I have reviewed this
Form 10-Q Quarterly Report
for the
quarterly period
ended
March 31, 2020
of T. Rowe Price Group, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
▪
|
Assets under management end quarter at
$1.01 trillion
|
▪
|
Net client outflows of
$6.0 billion
for Q1
2020
|
▪
|
Net revenues of
$1.5 billion
for Q1
2020
|
▪
|
Diluted earnings per common share of
$1.41
for Q1
2020
|
▪
|
Adjusted non-GAAP diluted earnings per common share of $1.87 for Q1
2020
|
▪
|
Repurchased 8.3 million shares at an average price of $106.43
|
▪
|
Long-term investment performance remains strong
|
Three Months ended
|
|||||||||||||||||
(in millions, except per-share data)
|
3/31/2020
|
3/31/2019
|
% change
|
12/31/2019
|
% change
|
||||||||||||
U.S. GAAP basis
|
|||||||||||||||||
Investment advisory fees
|
$
|
1,327.8
|
|
$
|
1,194.2
|
|
11.2
|
%
|
$
|
1,344.7
|
|
(1.3
|
)%
|
||||
Net revenues
|
$
|
1,462.6
|
|
$
|
1,327.3
|
|
10.2
|
%
|
$
|
1,468.7
|
|
(.4
|
)%
|
||||
Operating expenses
|
$
|
755.4
|
|
$
|
794.8
|
|
(5.0
|
)%
|
$
|
888.4
|
|
(15.0
|
)%
|
||||
Net operating income
|
$
|
707.2
|
|
$
|
532.5
|
|
32.8
|
%
|
$
|
580.3
|
|
21.9
|
%
|
||||
Non-operating income (loss)
(1)
|
$
|
(500.3
|
)
|
$
|
202.8
|
|
n/m
|
|
$
|
170.0
|
|
n/m
|
|
||||
Net income attributable to T. Rowe Price Group
|
$
|
343.1
|
|
$
|
512.6
|
|
(33.1
|
)%
|
$
|
545.3
|
|
(37.1
|
)%
|
||||
Diluted earnings per common share
|
$
|
1.41
|
|
$
|
2.09
|
|
(32.5
|
)%
|
$
|
2.24
|
|
(37.1
|
)%
|
||||
Weighted average common shares outstanding assuming dilution
|
236.8
|
|
239.6
|
|
(1.2
|
)%
|
237.4
|
|
(.3
|
)%
|
|||||||
Adjusted non-GAAP basis
(2)
|
|||||||||||||||||
Operating expenses
|
$
|
817.9
|
|
$
|
756.6
|
|
8.1
|
%
|
$
|
863.5
|
|
(5.3
|
)%
|
||||
Net operating income
|
$
|
647.2
|
|
$
|
572.2
|
|
13.1
|
%
|
$
|
605.7
|
|
6.9
|
%
|
||||
Non-operating income (loss)
(1)
|
$
|
(61.2
|
)
|
$
|
44.2
|
|
n/m
|
|
$
|
27.2
|
|
n/m
|
|
||||
Net income attributable to T. Rowe Price Group
|
$
|
454.3
|
|
$
|
460.6
|
|
(1.4
|
)%
|
$
|
495.0
|
|
(8.2
|
)%
|
||||
Diluted earnings per common share
|
$
|
1.87
|
|
$
|
1.87
|
|
—
|
%
|
$
|
2.03
|
|
(7.9
|
)%
|
||||
Assets under Management
(in billions)
|
|||||||||||||||||
Average assets under management
|
$
|
1,162.7
|
|
$
|
1,043.5
|
|
11.4
|
%
|
$
|
1,162.0
|
|
.1
|
%
|
||||
Ending assets under management
|
$
|
1,008.8
|
|
$
|
1,081.7
|
|
(6.7
|
)%
|
$
|
1,206.8
|
|
(16.4
|
)%
|
Three months ended 3/31/2020
|
|||||||||||||||
(in billions)
|
U.S. mutual funds
|
Subadvised and separate accounts
|
Other investment products
|
Total
|
|||||||||||
Assets under management at beginning of period
|
$
|
682.7
|
|
$
|
313.8
|
|
$
|
210.3
|
|
$
|
1,206.8
|
|
|||
Net cash flows before client transfers
|
(7.5
|
)
|
(3.5
|
)
|
5.0
|
|
(6.0
|
)
|
|||||||
Client transfers
|
(4.4
|
)
|
—
|
|
4.4
|
|
—
|
|
|||||||
Net cash flows after client transfers
|
(11.9
|
)
|
(3.5
|
)
|
9.4
|
|
(6.0
|
)
|
|||||||
Net market depreciation and losses
|
(108.4
|
)
|
(49.2
|
)
|
(34.3
|
)
|
(191.9
|
)
|
|||||||
Net distributions not reinvested
|
(.1
|
)
|
—
|
|
—
|
|
(.1
|
)
|
|||||||
Change during the period
|
(120.4
|
)
|
(52.7
|
)
|
(24.9
|
)
|
(198.0
|
)
|
|||||||
Assets under management at March 31, 2020
|
$
|
562.3
|
|
$
|
261.1
|
|
$
|
185.4
|
|
$
|
1,008.8
|
|
Three months ended 3/31/2020
|
|||||||||||||||
(in billions)
|
Equity
|
Fixed income, including money market
|
Multi-asset
(1)
|
Total
|
|||||||||||
Assets under management at beginning of period
|
$
|
698.9
|
|
$
|
147.9
|
|
$
|
360.0
|
|
$
|
1,206.8
|
|
|||
Net cash flows
|
(5.7
|
)
|
3.0
|
|
(3.3
|
)
|
(6.0
|
)
|
|||||||
Net market depreciation and losses
(2)
|
(123.9
|
)
|
(4.6
|
)
|
(63.5
|
)
|
(192.0
|
)
|
|||||||
Change during the period
|
(129.6
|
)
|
(1.6
|
)
|
(66.8
|
)
|
(198.0
|
)
|
|||||||
Assets under management at March 31, 2020
|
$
|
569.3
|
|
$
|
146.3
|
|
$
|
293.2
|
|
$
|
1,008.8
|
|
▪
|
Investment advisory revenues earned in Q
1
2020
from the firm's
U.S. mutual funds
were
$876.2 million
, an increase of
7.4%
from Q
1
2019
. Average assets under management in these funds increased
7.2%
to
$654.3 billion
in Q
1
2020
.
|
▪
|
Investment advisory revenues earned in Q
1
2020
from subadvised, separate accounts, and
other investment products
were
$451.6 million
,
an increase
of
19.4%
from Q
1
2019
. Average assets under management for these
products
increase
d
17.3%
to
$508.4 billion
in Q
1
2020
.
|
▪
|
The effective fee rate of
45.9 basis points
in Q
1
2020
, while flat compared to Q4
2019
, decreased compared to the 46.4 basis points earned in Q1 2019, primarily due to client transfers within the complex to lower fee vehicles or share classes over the last twelve months. Over time, the firm's effective fee rate can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures.
|
▪
|
Administrative, distribution, and servicing fees
in Q
1
2020
were
$134.8 million
,
an increase
of
1.3%
from
|
▪
|
Compensation and related costs
were
$440.7 million
in Q
1
2020
, a decrease of
10.3%
compared to
|
▪
|
Advertising and promotion expenses
were
$24.9 million
in Q
1
2020
, an increase of
15.3%
over Q
1
2019
. The increase was primarily driven by more television media activity in Q
1
2020
compared to Q
1
2019
.
|
▪
|
Technology, occupancy, and facility costs
were
$105.4 million
in Q
1
2020
,
an increase
of
7.4%
from the
$98.1 million
recognized in Q
1
2019
. The increase was due to the ongoing investment in the firm's technology capabilities, including related depreciation and hosted solution licenses.
|
▪
|
General, administrative, and other costs
were
$77.1 million
in Q
1
2020
,
an increase
of
5.6%
compared with the
$73.0 million
recognized in Q
1
2019
. The increase was primarily due to higher third-party investment research costs and professional fees. These higher costs were partially offset by lower travel expenses as global travel restrictions were put in place amid the coronavirus pandemic.
|
Three months ended
|
|||||
3/31/2020
|
3/31/2019
|
||||
Statutory U.S. federal income tax rate
|
21.0
|
%
|
21.0
|
%
|
|
State income taxes for current year, net of federal income tax benefits
(1)
|
6.4
|
|
4.2
|
|
|
Net losses (income) attributable to redeemable non-controlling interests
|
3.1
|
|
(.6
|
)
|
|
Net excess tax benefits from stock-based compensation plans activity
|
(8.1
|
)
|
(.6
|
)
|
|
Other items
|
(2.9
|
)
|
.7
|
|
|
Effective income tax rate
|
19.5
|
%
|
24.7
|
%
|
•
|
The firm's non-GAAP effective tax rate was
22.5%
in Q
1
2020
compared with
25.3%
in Q
1
2019
. The non-GAAP tax rate primarily adjusts for the impact of the consolidated investment products, including the significant net losses attributable to the redeemable non-controlling interests. The decrease in the non-GAAP effective tax rate is primarily due to the higher tax benefits associated with option exercises. The firm estimates that its effective tax rate for the full-year
2020
on a non-GAAP basis will be in the range of
23.5%
to
25.5%
.
|
(in millions)
|
3/31/2020
|
12/31/2019
|
||||||
Cash and cash equivalents
|
$
|
1,562.4
|
|
$
|
1,781.8
|
|
||
Discretionary investments
|
1,841.4
|
|
1,899.6
|
|
||||
Total cash and discretionary investments
|
3,403.8
|
|
3,681.4
|
|
||||
Redeemable seed capital investments
|
1,081.6
|
|
1,325.6
|
|
||||
Investments used to hedge the supplemental savings plan liability
|
500.0
|
|
561.1
|
|
||||
Total cash and investments in T. Rowe Price products
|
$
|
4,985.4
|
|
$
|
5,568.1
|
|
▪
|
The firm's common shares outstanding were
228.0 million
at
March 31, 2020
, compared with
235.2 million
at the end of
2019
.
|
▪
|
In Q1
2020
, the firm expended
$887.0 million
to repurchase
8.3 million
shares, or
3.5%
, of its outstanding common shares at an average price of
$106.43
.
|
▪
|
In February 2020, the firm increased its quarterly dividend by
18.4%
to $.90 per common share.
|
▪
|
The firm invested
$46.0 million
during Q1
2020
in capitalized facilities and technology and expects capital expenditures, including internal labor capitalization, for
2020
to be up to
$230 million
, of which about
three-quarters
is planned for technology initiatives. These expenditures are expected to continue to be funded from the firm's operating resources.
|
1 year
|
3 years
|
5 years
|
10 years
|
|||||
Outperformed Morningstar median
(2)
|
||||||||
All funds
|
50%
|
60%
|
72%
|
76%
|
||||
Multi-asset funds
|
44%
|
59%
|
76%
|
84%
|
||||
Top Morningstar quartile
(2)
|
||||||||
All funds
|
19%
|
28%
|
41%
|
50%
|
||||
Multi-asset funds
|
8%
|
24%
|
50%
|
68%
|
Public Relations
|
Investor Relations
|
||
Brian Lewbart
|
Meghan Azevedo
|
||
410-345-2242
|
410-345-2756
|
||
brian.lewbart@troweprice.com
|
meghan.azevedo@troweprice.com
|
Unaudited Consolidated Statements of Income
|
||||||||||||
(in millions, except per-share amounts)
|
||||||||||||
Three months ended
|
||||||||||||
Revenues
|
3/31/2020
|
3/31/2019
|
12/31/2019
|
|||||||||
Investment advisory fees
|
$
|
1,327.8
|
|
$
|
1,194.2
|
|
$
|
1,344.7
|
|
|||
Administrative, distribution, and servicing fees
|
134.8
|
|
133.1
|
|
124.0
|
|
||||||
Net revenues
|
1,462.6
|
|
1,327.3
|
|
1,468.7
|
|
||||||
Operating expenses
|
||||||||||||
Compensation and related costs
|
440.7
|
|
491.5
|
|
528.2
|
|
||||||
Distribution and servicing
|
65.7
|
|
66.4
|
|
67.2
|
|
||||||
Advertising and promotion
|
24.9
|
|
21.6
|
|
38.3
|
|
||||||
Product-related costs
|
41.6
|
|
44.2
|
|
37.6
|
|
||||||
Technology, occupancy, and facility costs
|
105.4
|
|
98.1
|
|
117.8
|
|
||||||
General, administrative, and other
|
77.1
|
|
73.0
|
|
99.3
|
|
||||||
Total operating expenses
|
755.4
|
|
794.8
|
|
888.4
|
|
||||||
Net operating income
|
707.2
|
|
532.5
|
|
580.3
|
|
||||||
Non-operating income (loss)
|
||||||||||||
Net gains (losses) on investments
|
(154.6
|
)
|
100.1
|
|
66.4
|
|
||||||
Net gains (losses) on consolidated investment products
|
(330.3
|
)
|
101.9
|
|
96.6
|
|
||||||
Other income (loss)
|
(15.4
|
)
|
.8
|
|
7.0
|
|
||||||
Total non-operating income (loss)
|
(500.3
|
)
|
202.8
|
|
170.0
|
|
||||||
Income before income taxes
|
206.9
|
|
735.3
|
|
750.3
|
|
||||||
Provision for income taxes
|
40.3
|
|
181.3
|
|
156.4
|
|
||||||
Net income
|
166.6
|
|
554.0
|
|
593.9
|
|
||||||
Less: net income (loss) attributable to redeemable non-controlling interests
|
(176.5
|
)
|
41.4
|
|
48.6
|
|
||||||
Net income attributable to T. Rowe Price Group
|
343.1
|
|
512.6
|
|
545.3
|
|
||||||
Less: net income allocated to outstanding restricted stock and stock unit holders
|
9.4
|
|
13.0
|
|
14.6
|
|
||||||
Net income allocated to T. Rowe Price Group common stockholders
|
$
|
333.7
|
|
$
|
499.6
|
|
$
|
530.7
|
|
|||
Earnings per share
|
||||||||||||
Basic
|
$
|
1.43
|
|
$
|
2.11
|
|
$
|
2.27
|
|
|||
Diluted
|
$
|
1.41
|
|
$
|
2.09
|
|
$
|
2.24
|
|
|||
Weighted-average common shares
|
||||||||||||
Outstanding
|
234.1
|
|
236.6
|
|
234.1
|
|
||||||
Outstanding assuming dilution
|
236.8
|
|
239.6
|
|
237.4
|
|
Investment Advisory Revenues (in millions)
|
Three months ended
|
||||||
3/31/2020
|
3/31/2019
|
||||||
U.S. mutual funds
|
|||||||
Equity and blended assets
|
$
|
749.8
|
|
$
|
694.5
|
|
|
Fixed income, including money market
|
126.4
|
|
121.4
|
|
|||
876.2
|
|
815.9
|
|
||||
Subadvised and separate accounts and other investment products
|
|||||||
Equity and blended assets
|
385.2
|
|
318.8
|
|
|||
Fixed income, including money market
|
66.4
|
|
59.5
|
|
|||
451.6
|
|
378.3
|
|
||||
Total
|
$
|
1,327.8
|
|
$
|
1,194.2
|
|
Assets Under Management (in billions)
|
Average during
|
|||||||||||||||
Three months ended
|
As of
|
|||||||||||||||
3/31/2020
|
3/31/2019
|
3/31/2020
|
12/31/2019
|
|||||||||||||
U.S. mutual funds
|
||||||||||||||||
Equity and blended assets
|
$
|
525.0
|
|
$
|
487.6
|
|
$
|
443.6
|
|
$
|
552.4
|
|
||||
Fixed income, including money market
|
129.3
|
|
122.5
|
|
118.7
|
|
130.3
|
|
||||||||
654.3
|
|
610.1
|
|
562.3
|
|
682.7
|
|
|||||||||
Subadvised and separate accounts and other investment products
|
||||||||||||||||
Equity and blended assets
|
396.3
|
|
332.9
|
|
340.9
|
|
412.1
|
|
||||||||
Fixed income, including money market
|
112.1
|
|
100.5
|
|
105.6
|
|
112.0
|
|
||||||||
508.4
|
|
433.4
|
|
446.5
|
|
524.1
|
|
|||||||||
Total
|
$
|
1,162.7
|
|
$
|
1,043.5
|
|
$
|
1,008.8
|
|
$
|
1,206.8
|
|
Net Cash Flows After Client Transfers (by investment vehicle and underlying asset class)(1)(2)
|
Three months ended
|
|||
(in billions)
|
3/31/2020
|
|||
U.S. mutual funds
|
||||
Equity and blended assets
|
$
|
(4.3
|
)
|
|
Fixed income, including money market
|
(7.6
|
)
|
||
(11.9
|
)
|
|||
Subadvised and separate accounts and other investment products
|
||||
Equity and blended assets
|
9.8
|
|
||
Fixed income, including money market
|
(3.9
|
)
|
||
5.9
|
|
|||
Total net cash flows after client transfers
|
$
|
(6.0
|
)
|
Non-Operating Income (Loss) (in millions)
|
Three months ended
|
||||||
3/31/2020
|
3/31/2019
|
||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products
|
|||||||
Cash and discretionary investments
|
|||||||
Dividend income
|
$
|
10.4
|
|
$
|
16.2
|
|
|
Market related gains (losses) and equity in earnings
|
(71.6
|
)
|
28.0
|
|
|||
Seed capital investments
|
|||||||
Dividend income
|
.7
|
|
.5
|
|
|||
Market related gains (losses) and equity in earnings
|
(34.1
|
)
|
19.6
|
|
|||
Net gain recognized upon deconsolidation
|
.1
|
|
.1
|
|
|||
Investments used to hedge the supplemental savings plan liability
|
(68.5
|
)
|
31.0
|
|
|||
Total net gains (losses) from non-consolidated T. Rowe Price investment products
|
(163.0
|
)
|
95.4
|
|
|||
Other investment income
|
8.4
|
|
4.7
|
|
|||
Net gains (losses) on investments
|
(154.6
|
)
|
100.1
|
|
|||
Net gains (losses) on consolidated sponsored investment portfolios
|
(330.3
|
)
|
101.9
|
|
|||
Other income (loss), including foreign currency gains and losses
|
(15.4
|
)
|
.8
|
|
|||
Non-operating income (loss)
|
$
|
(500.3
|
)
|
$
|
202.8
|
|
Unaudited Condensed Consolidated Cash Flows Information (in millions)
|
||||||||||||||||||||||||
Three months ended
|
||||||||||||||||||||||||
3/31/2020
|
3/31/2019
|
|||||||||||||||||||||||
Cash flow attributable to T. Rowe Price Group
|
Cash flow attributable to consolidated
T. Rowe Price investment products, net of eliminations
|
As reported on statement of cash flows
|
Cash flow attributable to T. Rowe Price Group
|
Cash flow attributable to consolidated
T. Rowe Price investment products, net of eliminations
|
As reported on statement of cash flows
|
|||||||||||||||||||
Cash provided by (used in) operating activities, including $58.3 of stock-based compensation expense and $46.1 of depreciation expense in 2020
|
$
|
864.0
|
|
$
|
(76.3
|
)
|
$
|
787.7
|
|
$
|
673.4
|
|
$
|
(94.7
|
)
|
$
|
578.7
|
|
||||||
Cash provided by (used in) investing activities, including $(46.0) for additions to property and equipment, $(225.1) of additions and $299.1M of dispositions to T. Rowe Price investment products in 2020
|
(15.0
|
)
|
42.6
|
|
27.6
|
|
(69.2
|
)
|
35.4
|
|
(33.8
|
)
|
||||||||||||
Cash provided by (used in) financing activities, including T. Rowe Price Group common stock repurchases of $(891.3)* and dividends paid of $(215.2) in 2020
|
(1,068.4
|
)
|
76.1
|
|
(992.3
|
)
|
(372.0
|
)
|
66.0
|
|
(306.0
|
)
|
||||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
—
|
|
(1.2
|
)
|
(1.2
|
)
|
—
|
|
(.7
|
)
|
(.7
|
)
|
||||||||||||
Net change in cash and cash equivalents during period
|
$
|
(219.4
|
)
|
$
|
41.2
|
|
$
|
(178.2
|
)
|
$
|
232.2
|
|
$
|
6.0
|
|
$
|
238.2
|
|
Unaudited Condensed Consolidated Balance Sheet Information (in millions)
|
As of
|
|||||||
3/31/2020
|
12/31/2019
|
|||||||
Cash and cash equivalents
|
$
|
1,562.4
|
|
$
|
1,781.8
|
|
||
Accounts receivable and accrued revenue
|
585.3
|
|
646.6
|
|
||||
Investments
|
2,731.3
|
|
2,939.8
|
|
||||
Assets of consolidated T. Rowe Price investment products
|
2,024.3
|
|
2,276.9
|
|
||||
Operating lease assets
|
137.6
|
|
110.8
|
|
||||
Property and equipment, net
|
675.2
|
|
674.4
|
|
||||
Goodwill
|
665.7
|
|
665.7
|
|
||||
Other assets
|
255.1
|
|
234.4
|
|
||||
Total assets
|
8,636.9
|
|
9,330.4
|
|
||||
Supplemental savings plan liability
|
504.2
|
|
563.4
|
|
||||
Total other liabilities, includes $82.9 at March 31, 2020, and $39.2 at December 31, 2019, from consolidated T. Rowe Price investment products
|
727.7
|
|
543.9
|
|
||||
Redeemable non-controlling interests
|
971.0
|
|
1,121.0
|
|
||||
Stockholders' equity, 228.0 common shares outstanding at March 31, 2020
|
$
|
6,434.0
|
|
$
|
7,102.1
|
|
Cash, Cash Equivalents, and Investments Information (in millions)
|
||||||||||||||||
Cash and cash equivalents
|
Investments
|
Net assets of consolidated T. Rowe Price investment products*
|
3/31/2020
|
|||||||||||||
Cash and discretionary investments
|
$
|
1,562.4
|
|
$
|
1,727.2
|
|
$
|
114.2
|
|
$
|
3,403.8
|
|
||||
Seed capital investments
|
—
|
|
225.4
|
|
856.2
|
|
1,081.6
|
|
||||||||
Investments used to hedge the supplemental savings plan liability
|
—
|
|
500.0
|
|
—
|
|
500.0
|
|
||||||||
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group
|
1,562.4
|
|
2,452.6
|
|
970.4
|
|
4,985.4
|
|
||||||||
Investment in UTI and other investments
|
—
|
|
278.7
|
|
—
|
|
278.7
|
|
||||||||
Total cash and investments attributable to T. Rowe Price Group
|
1,562.4
|
|
2,731.3
|
|
970.4
|
|
5,264.1
|
|
||||||||
Redeemable non-controlling interests
|
—
|
|
—
|
|
971.0
|
|
971.0
|
|
||||||||
As reported on unaudited condensed consolidated balance sheet at March 31, 2020
|
$
|
1,562.4
|
|
$
|
2,731.3
|
|
$
|
1,941.4
|
|
$
|
6,235.1
|
|
Three months ended 3/31/2020
|
|||||||||||||||||||||||
Operating expenses
|
Net operating income
|
Non-operating income (loss)
|
Provision (benefit) for income taxes
(4)
|
Net income attributable to T. Rowe Price Group
|
Diluted earnings per share
(5)
|
||||||||||||||||||
U.S. GAAP Basis
|
$
|
755.4
|
|
$
|
707.2
|
|
$
|
(500.3
|
)
|
$
|
40.3
|
|
$
|
343.1
|
|
$
|
1.41
|
|
|||||
Non-GAAP adjustments:
|
|||||||||||||||||||||||
Consolidated T. Rowe Price
investment products (1) |
(1.2
|
)
|
3.7
|
|
330.3
|
|
71.1
|
|
86.4
|
|
.36
|
|
|||||||||||
Supplemental savings plan liability
(2)
|
63.7
|
|
(63.7
|
)
|
68.5
|
|
2.1
|
|
2.7
|
|
.01
|
|
|||||||||||
Other non-operating income
(3)
|
—
|
|
—
|
|
40.3
|
|
18.2
|
|
22.1
|
|
.09
|
|
|||||||||||
Adjusted Non-GAAP Basis
|
$
|
817.9
|
|
$
|
647.2
|
|
$
|
(61.2
|
)
|
$
|
131.7
|
|
$
|
454.3
|
|
$
|
1.87
|
|
Three months ended 3/31/2019
|
|||||||||||||||||||||||
Operating expenses
|
Net operating income
|
Non-operating income (loss)
|
Provision (benefit) for income taxes
(4)
|
Net income attributable to T. Rowe Price Group
|
Diluted earnings per share
(5)
|
||||||||||||||||||
U.S. GAAP Basis
|
$
|
794.8
|
|
$
|
532.5
|
|
$
|
202.8
|
|
$
|
181.3
|
|
$
|
512.6
|
|
$
|
2.09
|
|
|||||
Non-GAAP adjustments:
|
|||||||||||||||||||||||
Consolidated T. Rowe Price
investment products (1) |
(1.6
|
)
|
3.1
|
|
(101.9
|
)
|
(18.9
|
)
|
(38.5
|
)
|
(.16
|
)
|
|||||||||||
Supplemental savings plan liability
(2)
|
(36.6
|
)
|
36.6
|
|
(31.0
|
)
|
1.8
|
|
3.8
|
|
.01
|
|
|||||||||||
Other non-operating income
(3)
|
—
|
|
—
|
|
(25.7
|
)
|
(8.4
|
)
|
(17.3
|
)
|
(.07
|
)
|
|||||||||||
Adjusted Non-GAAP Basis
|
$
|
756.6
|
|
$
|
572.2
|
|
$
|
44.2
|
|
$
|
155.8
|
|
$
|
460.6
|
|
$
|
1.87
|
|
Three months ended 12/31/2019
|
|||||||||||||||||||||||
Operating expenses
|
Net operating income
|
Non-operating income (loss)
|
Provision (benefit) for income taxes
(4)
|
Net income attributable to T. Rowe Price Group
|
Diluted earnings per share
(5)
|
||||||||||||||||||
U.S. GAAP Basis
|
$
|
888.4
|
|
$
|
580.3
|
|
$
|
170.0
|
|
$
|
156.4
|
|
$
|
545.3
|
|
$
|
2.24
|
|
|||||
Non-GAAP adjustments:
|
|||||||||||||||||||||||
Consolidated T. Rowe Price
investment products (1) |
(3.6
|
)
|
4.1
|
|
(96.6
|
)
|
(12.0
|
)
|
(31.9
|
)
|
(.13
|
)
|
|||||||||||
Supplemental savings plan liability
(2)
|
(21.3
|
)
|
21.3
|
|
(23.1
|
)
|
(.4
|
)
|
(1.4
|
)
|
(.01
|
)
|
|||||||||||
Other non-operating income
(3)
|
—
|
|
—
|
|
(23.1
|
)
|
(6.3
|
)
|
(16.8
|
)
|
(.07
|
)
|
|||||||||||
Adjusted Non-GAAP Basis
|
$
|
863.5
|
|
$
|
605.7
|
|
$
|
27.2
|
|
$
|
137.7
|
|
$
|
495.2
|
|
$
|
2.03
|
|
(1)
|
These non-GAAP adjustments remove the impact the consolidated T. Rowe Price investment products have on the firm's U.S. GAAP consolidated statements of income. Specifically, the firm adds back the operating expenses and subtracts the investment income of the consolidated T. Rowe Price investment products. The adjustment to operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interests. Management believes the consolidated T. Rowe Price investment products may impact the reader’s ability to understand the firm's core operating results.
|
(2)
|
This non-GAAP adjustment removes the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. The firm uses T. Rowe Price investment products to economically hedge the exposure to these market movements. Management believes it is useful to offset the non-operating investment income (loss) realized on the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period.
|
(3)
|
This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on the firm's non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and those non-consolidated investments that are not part of the cash and discretionary investment portfolio. Management retains the investment gains recognized on the non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of the firm's core operations. Management believes adjusting for these non-operating income (loss) items helps the reader’s ability to understand the firm's core operating results and increases comparability to prior years. Additionally, management does not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating the firm's performance.
|
(4)
|
The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of
22.5%
for
2020
,
25.3%
for Q1
2019
, and 21.8% for Q4 2019. The firm estimates that its effective tax rate for the full-year
2020
on a non-GAAP basis will be in the range of
23.5%
to
25.5%
.
|
(5)
|
This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows:
|
Three months ended
|
||||||||||
3/31/2020
|
|
3/31/2019
|
|
12/31/2019
|
|
|||||
Adjusted net income attributable to T. Rowe Price Group
|
$
|
454.3
|
|
$
|
460.6
|
|
$
|
495.2
|
|
|
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders
|
12.4
|
|
11.6
|
|
13.3
|
|
||||
Adjusted net income allocated to common stockholders
|
$
|
441.9
|
|
$
|
449.0
|
|
$
|
481.9
|
|